Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Functional characterization of cytochrome P450 2A6 (CYP2A6) allelic variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22

Kai Hung Tiong, Beow Chin Yap, Eng Lai Tan, Rusli Ismail and Chin Eng Ong
Drug Metabolism and Disposition February 5, 2010, dmd.109.031054; DOI: https://doi.org/10.1124/dmd.109.031054
Kai Hung Tiong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beow Chin Yap
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eng Lai Tan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rusli Ismail
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chin Eng Ong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ceong98@hotmail.com
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Variation in CYP2A6 levels and activity can be attributed to genetic polymorphism and thus, functional characterization of allelic variants is necessary to define the importance of CYP2A6 polymorphism in human. The present study aimed to investigate the reported allele CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22, in terms of the functional consequences of their mutations on the enzyme catalytic activity. Utilizing the wild type CYP2A6 cDNA as template, site-directed mutagenesis was carried out to introduce nucleotide changes encoding Lys194Glu substitution in CYP2A6*15, Arg203Ser substitution in CYP2A6*16, Lys476Arg substitution in CYP2A6*21 and concurrent Asp158Glu and Leu160Ile substitutions in CYP2A6*22. Upon sequence verification, the CYP2A6 wild type and mutant constructs were individually co-expressed with NADPH CYP-reductase in E. coli. Kinetic study using coumarin 7-hydroxylase assay indicated that CYP2A6*15 exhibited higer Vmax than the wild type while all mutant constructs, except for variant CYP2A6*16, exhibited higher Km values. Analysis of Vmax/Km ratio revealed that all mutants demonstrated 0.85- to 1.05-fold difference from the wild type, with exception of variant CYP2A6*22 which only portrayed 39% of the wild-type intrinsic clearance. These data suggested that individuals carrying CYP2A6*22 allele are likely to have lower metabolism of CYP2A6 substrate than individuals expressing CYP2A6*15, CYP2A6*16, CYP2A6*21 and the wild-type.

  • CYP2A
  • cytochrome P450
  • genetic polymorphism
  • pharmacogenetics
  • site-directed mutagenesis

Footnotes

    • Received December 1, 2009.
    • Accepted February 5, 2010.
  • The American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Drug Metabolism and Disposition: 50 (5)
Drug Metabolism and Disposition
Vol. 50, Issue 5
1 May 2022
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Functional characterization of cytochrome P450 2A6 (CYP2A6) allelic variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Functional characterization of cytochrome P450 2A6 (CYP2A6) allelic variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22

Kai Hung Tiong, Beow Chin Yap, Eng Lai Tan, Rusli Ismail and Chin Eng Ong
Drug Metabolism and Disposition February 5, 2010, dmd.109.031054; DOI: https://doi.org/10.1124/dmd.109.031054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Functional characterization of cytochrome P450 2A6 (CYP2A6) allelic variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22

Kai Hung Tiong, Beow Chin Yap, Eng Lai Tan, Rusli Ismail and Chin Eng Ong
Drug Metabolism and Disposition February 5, 2010, dmd.109.031054; DOI: https://doi.org/10.1124/dmd.109.031054
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics